These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Neuroleptic malignant syndrome in users of risperidone]. Bonte-Mineur F, Geerlings CJ, Rietveld AP. Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595 [No Abstract] [Full Text] [Related]
7. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J. World J Biol Psychiatry; 2009 Jan 15; 10(1):70-3. PubMed ID: 19673089 [Abstract] [Full Text] [Related]